Kolexia
Portal-Bartolomei Isabelle Gastro-entérologie
Portal-Bartolomei Isabelle
Gastro-entérologie
Hôpital La Timone
Marseille, France
54 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite C chronique Hépatite chronique Hépatite B Cirrhose du foie Fibrose Carcinome hépatocellulaire Tumeurs du foie

Collaborateurs

Voir plus
Bourliere Marc
Bourliere Marc
Hopital Saint Joseph, Marseille, France
Tran Albert
Tran Albert
Hôpital De l'Archet, Nice, France
Oules-Guieu Valerie
Oules-Guieu Valerie
Centre D'imagerie Monticelli Velodrome, Marseille, France
Castellani Paul
Castellani Paul
Hôpital La Casamance, Aubagne, France

Industries

Voir plus
Gilead
18 collaboration(s)
Dernière en 2023
Abbvie
13 collaboration(s)
Dernière en 2023
A+A
4 collaboration(s)
Dernière en 2020
MSD
3 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
HEPATHER: Therapeutic Option for Hepatitis B and C: a French Cohort
Essai Clinique (BMS)   30 janvier 2023
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC infectious diseases   27 janvier 2022
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Clinics and research in hepatology and gastroenterology   27 avril 2021
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet (London, England)   11 février 2019
CUPIC: Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) Included in the French Early Access Program for the Use of Protease Inhibitors in Genotype 1 Patients Who Failed to Eradicate HCV With a Previous Standard PEG-IFN and RBV Combination.
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   23 janvier 2017
Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study.
Annales de dermatologie et de venereologie   06 mai 2016
Multidisciplinary approach for the treatment of 1155 HCV/HCV-HIV co-infected patients
Abstracts of the 2016 International Symposium on HIV and Emerging Infectious Diseases (ISHEID), 25–27 May 2016, Marseille, France   01 mai 2016
Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.
Expert review of gastroenterology & hepatology   23 novembre 2015
Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase.
Virology   14 juillet 2015
P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic
Abstracts of The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver   01 avril 2015